Jazz Pharmaceuticals Director Laura Hamill Sells Shares for Tax Withholding

What Happened Laura Hamill, a director of Jazz Pharmaceuticals (JAZZ), disposed of a total of 1,706 shares on August 31, 2026 to satisfy tax withholding obligations from vested restricted stock units (RSUs). The sales consisted of 1,692 shares at $241.39 each ($408,432) and 14 shares at $244.06 each ($3,417), for a combined proceeds of roughly $411,849. The transactions are reported under code F (payment of tax liability).

Key Details

• Transaction date: August 31, 2026 (Filed Sept 2, 2026)
• Prices and quantities: 1,692 shares @ $241.39; 14 shares @ $244.06
• Total shares sold: 1,706; approximate total proceeds: $411,849
• Transaction code: F — shares sold to satisfy tax obligations on vested RSUs (Footnote F1)
• Shares owned after the transaction: not disclosed in this filing
• Filing timeliness: report filed Sept 2, 2026; no late‑filing flag reported in the form

Context These sales were a sell‑to‑cover (tax withholding) related to RSU vesting, a common and routine insider transaction that does not necessarily indicate a change in the insider’s view of the company. For retail investors, purchases or open‑market buys typically carry more informational weight than routine tax withholdings.